Other The innovators working to make in vivo cell therapy a reality Pharmaceutical TechnologyAs in vivo cell therapies enter clinical trials, suppliers tackle the technical and logistical barriers to commercial viability.OtherGene Therapy PlatformRead full story pharminent April 17, 2026 (Last updated: April 17, 2026) Pharmaceutical Technology As in vivo cell therapies enter clinical trials, suppliers tackle the technical and logistical barriers to commercial viability. OtherGene Therapy PlatformRead full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: Trump names Erica Schwartz to fill leadership void at CDCNext: Aligos and Xiamen Amoytop sign deal for HBV therapy Related Stories Other ASCO ’26: Bispecifics vs. ADCs, a ‘RAS’ revolution and a step change in prostate cancer pharminent June 2, 2026 Other ASCO26: Symptom-tracking app helps advanced cancer patients pharminent June 2, 2026 Other All eyes on Revolution, bispecific antibodies and more at ASCO26 pharminent May 26, 2026
